Medical life sciences industry intelligence is widely scattered and tough to track. Keep up to date with “Economic Issues in U.S. Healthcare” Breaking News on MedIntelliBlog – simply access and/or subscribe to the 25-story feed by visiting:
Current News “Top Picks” by MIB Editors…
Fear surrounds deal between nonprofit hospital, for-profit company
FierceHealthcare, 2010-07-14
“As nonprofit hospitals become increasingly attractive to for-profit companies looking to capture…”
Business versus Obama
MarketWatch, 2010-07-14
“When in doubt, whine about the government. That seems to be the latest corporate strategy…”
U.S. Advisers Say Keep Glaxo’s Avandia on Market
Reuters via BNET, 2010-07-14
“U.S. health advisers said GlaxoSmithKline Plc’s (GSK) diabetes drug Avandia should be allowed to…”
RXi Pharmaceuticals receives SBIR grant from National Institute of Allergy and Infectious Diseases
Trading Markets, 2010-07-14
“RXi Pharmaceuticals Corporation, a RNAi-based therapeutic discovery and development company…”
Most Read News from Last Week…
Obama bypasses Senate for new Medicare chief
The Associated Press via The Seattle Times, 2010-07-07
Drug Prices in the US: Not So High After All?
Corante, 2010-07-07
Domestic medical travel could ratchet up pressure on local providers
FierceHealthcare, 2010-07-07
Generex Biotechnology Participates in Gateway to China Business Round Table Conference
Market Watch, 2010-07-07
Stay alert, be intelligent -
Jordan Zornes – Editor & Senior Analyst
Victoria Hunsicker Sanko – Senior Editor
Subscribe to “Economic Issues in U.S. Healthcare” Breaking News”
Related posts:
